Diagnosis and management of the solitary pulmonary nodule

BMJ (Online)

Volumn 343, Issue 7836, 2011, Pages 1274-

  Weir, Graeme ^a   Kos, Sebastian ^a   Burrill, Josh ^a   Salat, Peter ^a   Ho, Stephen ^a   Liu, David ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; CHEMORADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG BIOPSY; LUNG NODULE; LUNG NON SMALL CELL CANCER; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THORAX RADIOGRAPHY; TUMOR ABLATION; BIOPSY; CATHETER ABLATION; LUNG; LUNG TUMOR; PATHOLOGY; SCINTISCANNING;

AGED; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SOLITARY PULMONARY NODULE;

EID: 83755173290     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d4866     Document Type: Article

References (22)

1. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests and paraneoplastic syndromes. Chest 2003;123(1 suppl):97S-104S. (Pubitemid 36135707)
2. Thirumaran M, Sundar R, Sutcliffe IM, Currie DC. Is investigation of patients with haemoptysis and normal chest radiograph justified? Thorax 2009;64:854-6.
3. Westcott JL. Direct percutaneous needle aspiration of localized pulmonary lesions: results in 422 patients. Radiology 1980;137:31-5. (Pubitemid 10002549)
4. Macfarlane J. Lung biopsy. BMJ 1985;290:97-8. (Pubitemid 15122943)
5. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: Summary of published evidence. Chest 2003;123(1 Supp1):115S-28S. (Pubitemid 36135709)
6. Detterbeck FC, Rivera M. Clinical presentation and diagnosis. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and treatment of lung cancer: an evidence-based guide for the practicing clinician, 4. WB Saunders, 2001:45-72.
7. Prosch H, Strasser G, Oschatz E, Schober E, Schneider B, Mostbeck GH. Management of patients with small pulmonary nodules: a survey of radiologists, pulmonologists, and thoracic surgeons. AJR Am J Roentgenol 2006;187:143-8. (Pubitemid 46100160)
8. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-7. (Pubitemid 36706537)
9. National Institute for Health and Clinical Excellence. The diagnosis and treatment of lung cancer. 2005. www.nice.org.uk/nicemedia/live/13465/54199/ 54199.pdf.
10. Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with lung cancer (SIGN publication 80). 2005. www.sign.ac.uk/pdf/ sign80.pdf.
11. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32-9.
12. Van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359:1388-93.
13. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003;229:526-33. (Pubitemid 37310842)
14. Zee YK, Eisen T. Survival from lung cancer in England and Wales up to 2001. Br J Cancer 2008;99(suppl 1):S43-6.
15. Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 2008;15:1765-74.
16. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
17. Manser R, Wright G, Hart D, Hart D, Campbell DA. Surgery for local and locally advanced non-small cell lung cancer (review). Cochrane Database Syst Rev 2005;1:CD004699.
18. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines. (2nd ed). Chest 2007;132(3 suppl):243S-65S. (Pubitemid 47502811)
19. Azzoli CG, Baker S, Temin S, Pao W, Aliff T, Brahmer J, et al. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 2009;27:6251-66.
20. Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621-8.
21. Choe YH, Kim SR, Lee KS, Lee KY, Park SJ, Jin G, et al. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Eur J Cancer 2009;45:1773-9.
22. Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738-45.